Durbin, Braun Urge FDA To Crack Down On Misleading Social Media Ads That Promote Prescription Drugs
WASHINGTON – U.S. Senate Majority Whip Dick Durbin (D-IL) and U.S. Senator Mike Braun (R-IN) urged the Food and Drug Administration (FDA) to take swift action to update its enforcement tools to reflect the current social media platforms and tactics used to promote prescription drugs, and to prioritize the protection of children from harmful and inaccurate medical advice. With the dramatic rise in social media use—especially among youth—there has been an alarming proliferation of dangerous and misleading content promoting prescription drugs. The bipartisan pairing of Senators request answers from FDA on their actions to crack down on these targeted ads by March 27, 2024. The Senators wrote, “Studies show that patients are more likely to ask their provider for a particular medication and to receive a prescription if the patient has seen a direct-to-consumer (DTC) advertisement for the drug. This can inflate demand for medications that may not be clinically
stLouIST